Anti-epidemic white paper: COVID-19 treatment costs are fully borne by the country
"The COVID-19 epidemic is a major public health emergency that has occurred since the founding of New China, with the fastest spread, the widest infection range, and the most difficult prevention and control." On June 7, the "Combat COVID- The 19 White Paper on China Action for Epidemic Situation (hereinafter referred to as "White Paper") defines the epidemic situation in this way. From the closure of Wuhan to the home of the whole people, from clinical treatment to vaccine research and development... This epidemic blocking war achieved initial results, but it also exposed the problems in the public health field. During the two sessions of this year, the public health emergency management system was built. Being put on the forefront, early warning and monitoring systems, management of disease control agencies, and public health regulations will become the top priorities for the next shortcomings.
Per capita cost 23,000 yuan
"White Paper" shows that as of 24:00 on May 31, 2020, the cure rate of COVID-19 was 94.3%, and the mortality rate was 5.6%.
Specifically, 31 provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps have reported a total of 83,017 confirmed cases, a total of 78,307 discharged cases and a total of 4,634 deaths.
"Since the outbreak, Hubei Province has successfully cured more than 3,000 COVID-19 patients over 80 years old and 7 over 100 years old. Many severely ill elderly patients were rescued from the death line." The White Paper pointed out.
Behind the high cure rate is the high cost of treatment. According to the "White Paper", as of May 31, the per capita medical expenses of diagnosed patients nationwide were about 23,000 yuan, and the total medical expenses were as high as 1.35 billion yuan.
It is worth noting that the treatment cost of severe patients is much higher than that of ordinary patients. "The per capita cost of treatment for critically ill patients exceeds 150,000 yuan, and the cost of treatment for some critically ill patients is hundreds of thousands of yuan or even millions." "White Paper" pointed out. Among them, a 70-year-old man suffering from COVID-19, treatment costs nearly 1.5 million yuan.
For the source of the cost, the "White Paper" uses seven words to describe it: all are borne by the state.
The "White Paper" shows that as of May 31, all levels of finance across the country have allocated 162.4 billion yuan in epidemic prevention and control funds. Specifically, for the medical expenses incurred by COVID-19 patients (including diagnosed and suspected patients), after basic medical insurance, critical illness insurance, medical assistance, etc. are paid according to the regulations, the personal burden will be subsidized by the financial; Advance payment shall be made by the medical insurance department at the place of medical treatment. In order to ensure that medical institutions do not worry about budgetary restrictions, the National Medical Insurance Bureau has previously stated that the medical insurance department timely adjusts the total budget indicators of designated medical institutions for treatment, lists the related medical expenses separately, and does not occupy the total budget indicators of the year.
"In fact, for the poor or those who have no ability to pay, especially the emergency department, our public hospitals have also treated them first. However, in the case of large-scale epidemics, we must rely on financial subsidies and the government will exempt medical insurance. All expenses." Xue Di, a professor at the School of Public Health of Fudan University, said in an interview with a reporter from the Beijing Commercial Daily.